Multiple Assemblies exist for SMTL entry 4wzv
Crystal structure of a hydroxamate based inhibitor EN140 in complex with the MMP-9 catalytic domain; X-RAY DIFFRACTION 1.65 Å

	SMTL ID 4wzv.1 Ligands (2R)-4-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-hydroxy-2-{[(4'-methoxybiphenyl-4-yl)sulfonyl](propan-2-yloxy)amino}butanamide; ZINC ION; CALCIUM ION; 1,2-ETHANEDIOL; S-1,2-PROPANEDIOL; DI(HYDROXYETHYL)ETHER Polypeptides Matrix metalloproteinase-9,Matrix metalloproteinase-9 Oligo-state monomer
	SMTL ID 4wzv.2 Ligands (2R)-4-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-hydroxy-2-{[(4'-methoxybiphenyl-4-yl)sulfonyl](propan-2-yloxy)amino}butanamide; ZINC ION; CALCIUM ION; 1,2-ETHANEDIOL; AZIDE ION; SODIUM ION; GLYCEROL; DI(HYDROXYETHYL)ETHER Polypeptides Matrix metalloproteinase-9,Matrix metalloproteinase-9 Oligo-state monomer